Photosensitizing action of isomeric zinc N-methylpyridylporphyrins in human carcinoma cells.

The success of photodynamic therapy (PDT), as a minimally invasive approach, in treating both neoplastic and non-neoplastic diseases has stimulated the search for new compounds with potential application in PDT. We have previously reported that Zn(II) N-alkylpyridylporphyrins (ZnTM-2(3,4)-PyP(4+) and ZnTE-2-PyP(4+)) can act as photosensitizers and kill antibiotic-resistant bacteria. This study investigated the photosensitizing effects of the isomers of ZnTMPyP(4+) (ZnTM-2(3,4)-PyP(4+)) and respective ligands on a human colon adenocarcinoma cell line. At 10 microM and 30 min of illumination the isomeric porphyrins completely inhibited cell growth, and at 20 microM killed approximately 50% of the cancer cells. All these effects were entirely light-dependent. The isomers of the ZnTMPyP(4+) and the respective ligands show high photosensitizing efficiency and no toxicity in the dark. Their efficacy as photosensitizers is comparable to that of hematoporphyrin derivative (HpD).